SEC Form 4 · accession 0001144204-19-003872

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Exec. VP, Corporate Strategy · Director

Period of report

Jan 28, 2019

Accepted (ET)

Jan 30, 2019 · 9:07 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Jan 28, 2019	M	2,500	$11.83	A	2,500	D
Class A Common Stock^F2	Jan 28, 2019	S	2,500	$31.55	D	0	D
Class A Common Stock	Jan 29, 2019	M	4,890	$11.83	A	4,890	D
Class A Common Stock^F3	Jan 29, 2019	S	4,890	$31.32	D	0	D
Class A Common Stock	Jan 30, 2019	M	2,390	$11.83	A	2,390	D
Class A Common Stock^F4	Jan 30, 2019	S	2,390	$31.15	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Common Stock	$11.83	Jan 28, 2019	M	2,500	D	Mar 1, 2013	Feb 28, 2019	Class A Common Stock	2,500	7,280	D
Option to purchase Common Stock	$11.83	Jan 29, 2019	M	4,890	D	Mar 1, 2013	Feb 28, 2019	Class A Common Stock	4,890	2,390	D
Option to purchase Common Stock	$11.83	Jan 30, 2019	M	2,390	D	Mar 1, 2014	Feb 28, 2019	Class A Common Stock	2,390	0	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.19 to $32.08, inclusive.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.08 to $31.73, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.04 to $31.30, inclusive.